Kyle and Joe - Solidarity Fridays - Week 5
Release Date: 05/01/2020
In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...info_outline Ash - CBD, Nootropics, and Micro1p
In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective. Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...info_outline Solidarity Fridays - Week 24
In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....info_outline Wade Davis - Ayahuasca and a New Hope for Colombia
In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th. Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...info_outline Solidarity Fridays - Week 23
In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...info_outline Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens
In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...info_outline Solidarity Fridays - Week 22
In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...info_outline Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity
In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...info_outline Solidarity Fridays - Week 21
In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab. They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...info_outline Jerry and Julie Brown - Healing Through Mystical Experience
In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...info_outline
In today’s Solidarity Friday’s Episode with Kyle and Joe, they talk mostly about Corpora-delic, companies and wealthy individuals investing in the psychedelic industry.
Support the show
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
- The company is valued at 111 million
- The CEO, Jason Hobson says, “The current health pandemic has resulted in a societal shift in the way we think about our health and the importance of access to treatment, both physical health and mental health. Ei.Ventures believes this is the right time to lean into mental health issues such as mood disorders and addiction, and eventual access to therapeutic treatments from innovations in botanical compounds that have been around for thousands of years.”
- Joe and Kyle say that there is so much money coming in, and it worries the psychedelic community because they aren't used to seeing capitalism
- Joe says that he hopes that some patents don't equate to ruining access
- “Are these companies going to bully the smaller organizations out of existence so that diversity doesn't really exist in the way we think it should?” - Joe
- Medical is a great model, but it should be reduced to that only
- Kyle says the sacred-ness feels like it may be taken away, and big companies just look at it as a commodity
- "Not everyone sees this opportunity for entrepreneurship as a good thing. For researchers looking into the efficacy of psychedelics for therapeutic purposes, these substances are far more than a market opportunity—they’re potentially life-saving medications. And after decades of prohibition, psychedelics are just barely gaining mainstream acceptance.’ - from the article
- People are bold enough to stand up to companies they don't agree with
It's no joke how much money was spent on making Tim Leary look bad
- The Defense Advanced Research Projects Agency (DARPA) is launching a new drug program for treating soldiers with PTSD, depression, anxiety, and drug addiction, and it is drawing inspiration from psychedelic research.
- Kyle mentions that this is tricky, its both a biochemical and experiential thing
- Will eliminating the hallucinations ruin the experience?
- Joe says that there are some people that are so unstable that a psychedelic experience can be really a lot
- Joe also says that there arent alot of drugs that their use needs to be supervised (medically) and psychedelics are some of them
- Joe recorded with Erica Darragh from Sunrise Movement
- Their talk was about how climate justice could end the drug war
- They talked about more equitable ways of including people of less power, influence or privilege into the world of psychedelics
- The more ahead we are of the government, the more likely we are to influence policy, Joe says it's best to just stay informed
- If we aren't coming from psychedelic values when bringing these substances into the mainstream, then what are we doing?
- What are psychedelic values?
- Valuing the planet, valuing your place in the planet, a sense of connection, cooperation vs. competition, how do we honor a lineage or where these medicines come from? these could be some psychedelic values
- Following the permaculture principles and applying them to life is a great tool for systems thinking
Kyle’s interest in exploring non-ordinary states of consciousness began when he was 16-years-old when he suffered a traumatic snowboarding accident. Waking up after having a near-death experience changed Kyle’s life. Since then, Kyle has earned his B.A. in Transpersonal Psychology, where he studied the healing potential of non-ordinary states of consciousness by exploring shamanism, plant medicine, Holotropic Breathwork, and the roots/benefits of psychedelic psychotherapy. Kyle has co-taught two college-level courses. One of the courses Kyle created as a capstone project, “Stanislav Grof’s Psychology of Extraordinary Experiences,” and the other one which he co-created, “The History of Psychedelics.”
Kyle completed his M.S. in clinical mental health counseling with an emphasis in somatic psychology. Kyle’s clinical background in mental health consists of working with at-risk teenagers in crisis and with individuals experiencing an early-episode of psychosis. Kyle also facilitates Transpersonal Breathwork workshops.
Joe studied philosophy in New Hampshire, where he earned his B.A.. After stumbling upon the work of Stanislav Grof during his undergraduate years, Joe began participating in Holotropic Breathwork workshops in Vermont in 2003. Joe helped facilitate Holotropic and Transpersonal Breathwork workshops while he spent his time in New England. He is now working in the software industry as well as hosting a few podcasts. Joe now coordinates Dreamshadow Transpersonal Breathwork workshops, in Breckenridge, Colorado.audibletrial.com/psychedelicstoday